Incyte’s pipeline updates on Monday bring into question the value of its $750 million Escient acquisition in April 2024—and ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...

Another related condition, aquagenic pruritus (AP), causes intense itching upon water contact. Here's what you need to know ...

A pruritus-free day was defined as the absence ... prior to unblinding with the WHO-ART dictionary. All resources with URTICARIA in their preferred term were selected. All medical resources ...

About 30% of patients who have skin disorders are reported to have psychiatric disorders and psychosocial impairments (Kessler et al., 2005). The prevalence of psychological disorders among ...

Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...

Report Ocean has published a new report on the Pruritus Therapeutics Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...